- Home
- CRIS vs FEAM Comparison
CRIS vs FEAM Comparison
Compare CRIS & FEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- FEAM
- Stock Information
- Founded
- CRIS 2000
- FEAM 2016
- Country
- CRIS United States
- FEAM United States
- Employees
- CRIS N/A
- FEAM N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- FEAM Major Chemicals
- Sector
- CRIS Health Care
- FEAM Industrials
- Exchange
- CRIS Nasdaq
- FEAM Nasdaq
- Market Cap
- CRIS 21.3M
- FEAM 70.5M
- IPO Year
- CRIS 2000
- FEAM N/A
- Fundamental
- Price
- CRIS $1.81
- FEAM $3.61
- Analyst Decision
- CRIS Strong Buy
- FEAM Strong Buy
- Analyst Count
- CRIS 2
- FEAM 2
- Target Price
- CRIS $16.50
- FEAM $121.00
- AVG Volume (30 Days)
- CRIS 163.8K
- FEAM 15.1K
- Earning Date
- CRIS 07-31-2025
- FEAM 09-03-2025
- Dividend Yield
- CRIS N/A
- FEAM N/A
- EPS Growth
- CRIS N/A
- FEAM N/A
- EPS
- CRIS N/A
- FEAM N/A
- Revenue
- CRIS $11,202,000.00
- FEAM N/A
- Revenue This Year
- CRIS N/A
- FEAM N/A
- Revenue Next Year
- CRIS $10.67
- FEAM N/A
- P/E Ratio
- CRIS N/A
- FEAM N/A
- Revenue Growth
- CRIS 14.17
- FEAM N/A
- 52 Week Low
- CRIS $1.02
- FEAM $2.82
- 52 Week High
- CRIS $8.29
- FEAM $27.14
- Technical
- Relative Strength Index (RSI)
- CRIS 43.58
- FEAM 44.88
- Support Level
- CRIS $1.50
- FEAM $3.42
- Resistance Level
- CRIS $1.98
- FEAM $3.75
- Average True Range (ATR)
- CRIS 0.19
- FEAM 0.25
- MACD
- CRIS -0.05
- FEAM 0.02
- Stochastic Oscillator
- CRIS 43.88
- FEAM 45.16
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About FEAM 5E Advanced Materials Inc.
5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.